Kodi-M Co Ltd (224060) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kodi-M Co Ltd (224060) has a cash flow conversion efficiency ratio of -1.298x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-8.54 Billion ≈ $-5.79 Million USD) by net assets (₩6.58 Billion ≈ $4.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kodi-M Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Kodi-M Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Kodi-M Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kodi-M Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kodi-M Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Denali Capital Acquisition Corp. Class A Ordinary Shares
NASDAQ:DECA
|
0.008x |
|
Mlk Foods Public Company Ltd
WAR:MLK
|
0.004x |
|
MMAG Holdings Bhd
KLSE:0034
|
0.684x |
|
Klassik Radio AG
XETRA:KA8
|
-0.090x |
|
Intrasoft Technologies Limited
NSE:ISFT
|
0.038x |
|
TIALIS ESSENTIAL IT PLC
F:U6M
|
N/A |
|
Omineca Mining and Metals Ltd
V:OMM
|
-0.046x |
|
A1 Investments & Resources Ltd
AU:AYI
|
0.118x |
Annual Cash Flow Conversion Efficiency for Kodi-M Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Kodi-M Co Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 224060 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩10.75 Billion ≈ $7.29 Million |
₩-3.68 Billion ≈ $-2.49 Million |
-0.342x | -190.56% |
| 2024-12-31 | ₩45.19 Billion ≈ $30.63 Million |
₩-5.32 Billion ≈ $-3.60 Million |
-0.118x | +42.92% |
| 2023-12-31 | ₩32.17 Billion ≈ $21.80 Million |
₩-6.63 Billion ≈ $-4.49 Million |
-0.206x | +43.10% |
| 2022-12-31 | ₩46.97 Billion ≈ $31.83 Million |
₩-17.02 Billion ≈ $-11.53 Million |
-0.362x | -86.76% |
| 2021-12-31 | ₩55.69 Billion ≈ $37.74 Million |
₩-10.80 Billion ≈ $-7.32 Million |
-0.194x | +31.34% |
| 2020-12-31 | ₩79.93 Billion ≈ $54.17 Million |
₩-22.59 Billion ≈ $-15.31 Million |
-0.283x | +8.88% |
| 2019-12-31 | ₩65.51 Billion ≈ $44.39 Million |
₩-20.31 Billion ≈ $-13.77 Million |
-0.310x | -1368.33% |
| 2018-12-31 | ₩56.29 Billion ≈ $38.15 Million |
₩1.38 Billion ≈ $932.73K |
0.024x | +288.85% |
| 2017-12-31 | ₩55.27 Billion ≈ $37.45 Million |
₩-715.52 Million ≈ $-484.90K |
-0.013x | +97.41% |
| 2016-12-31 | ₩15.85 Billion ≈ $10.74 Million |
₩-7.91 Billion ≈ $-5.36 Million |
-0.499x | -377.13% |
| 2015-12-31 | ₩12.28 Billion ≈ $8.32 Million |
₩2.21 Billion ≈ $1.50 Million |
0.180x | -- |
About Kodi-M Co Ltd
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and chang… Read more